Loading...
Celcuity Inc (CELC) is not a strong buy at the moment for a beginner, long-term investor with $50,000-$100,000 to invest. While there are positive analyst ratings and potential upside due to upcoming catalysts, insider selling, weak financial performance, and lack of strong technical or proprietary trading signals suggest caution. Holding the stock or waiting for better entry points may be more prudent.
The MACD histogram is negative (-1.166) and contracting, RSI is neutral at 39.304, and moving averages are converging, indicating no clear trend. The stock is trading below the pivot level of 106.382, with key support at 99.884 and resistance at 112.879.

Analysts from Wells Fargo and Wolfe Research have initiated coverage with Overweight/Outperform ratings and price targets of $126 and $110, respectively. The upcoming VIKTORIA-1 PI3KCA mutant readout is seen as largely de-risked, and the company is viewed as a potential acquisition target.
Insider selling has increased significantly (657.10% over the last month), and the stock has appreciated 608% year-to-date, raising concerns about overvaluation. H.C. Wainwright downgraded the stock to Neutral, citing downside risk at current levels. Additionally, there is no recent Congress trading data or strong proprietary trading signals.
In Q3 2025, revenue remained at 0 with no YoY growth. Net income improved by 47.03% YoY to -$43.8 million, and EPS improved by 31.43% YoY to -0.92. However, the company remains unprofitable, with no gross margin.
Analysts are generally positive, with Wells Fargo and Wolfe Research initiating coverage with high price targets. However, H.C. Wainwright downgraded the stock to Neutral, citing overvaluation concerns and limited upside potential.